The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
A caspase-resistant mutant of PKC-δ protects keratinocytes from UV-induced apoptosis
D'Costa, A. M., & Denning, M. F. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401558 · Cited by 69
Weichert, W., Gekeler, V., Denkert, C., Dietel, M., & Hauptmann, S. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.3.633 · Cited by 69
Kim, J., Thorne, S. H., Sun, L., Huang, B., & Mochly‐Rosen, D. (2010) · Oncogene · doi:10.1038/onc.2010.415 · Cited by 68
Varga, A., Czifra, G., Tállai, B., Németh, T., Kovács, I., Kovács, L., & Bíró, T. (2004) · European Urology · doi:10.1016/j.eururo.2004.04.014 · Cited by 67
Midostaurin in Advanced Systemic Mastocytosis
Chandesris, M., Damaj, G. L., Canioni, D., Brouzes, C., Lhermitte, L., Hanssens, K., Frenzel, L., Cherquaoui, Z., Durieu, I., Durupt, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1515403 · Cited by 67
Advani, R. H., Peethambaram, P. P., Lum, B. L., Fisher, G. A., Hartmann, L. C., Long, H. J., Halsey, J., Holmlund, J., Dorr, A., & Sikic, B. I. (2004) · Cancer · doi:10.1002/cncr.11909 · Cited by 65
Ferreira, J. C. B., Brum, P. C., & Mochly‐Rosen, D. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.020 · Cited by 64
Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells
Drexler, H. G., Gignac, S. M., Jones, R., Cs, S., Pettit, G., & Hoffbrand, A. V. (1989) · Blood · doi:10.1182/blood.v74.5.1747.bloodjournal7451747 · Cited by 63
The proapoptotic tumor suppressor protein kinase C-δ is lost in human squamous cell carcinomas
D'Costa, A. M., Robinson, J. K., Maududi, T., Chaturvedi, V., Nickoloff, B. J., & Denning, M. F. (2005) · Oncogene · doi:10.1038/sj.onc.1209065 · Cited by 62
Activation of PKC is sufficient to induce an apoptotic program in salivary gland acinar cells
Reyland, M. E., Barzen, K. A., Anderson, S. M., Quissell, D. O., & Matassa, A. A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400744 · Cited by 62
PKC Delta (PKCδ) Promotes Tumoral Progression of Human Ductal Pancreatic Cancer
Mauro, L. V., Grossoni, V. C., Urtreger, A. J., Yang, C., Colombo, L. L., Morandi, A., Pallotta, M. G., Kazanietz, M. G., Joffé, E. B. D. K., & Puricelli, L. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181bce796 · Cited by 62
Okhrimenko, H., Lü, W., Xiang, C., Ju, D., Blumberg, P. M., Gomel, R., Kazimirsky, G., & Brodie, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501374200 · Cited by 61
Mansfield, A. S., Fields, A. P., Jatoi, A., Qi, Y., Adjei, A. A., Erlichman, C., & Molina, J. R. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000009 · Cited by 59
Han, Z. T., Tong, Y. K., He, L. M., Zhang, Y., Sun, J. Z., Wang, T. Y., Zhang, H., Cui, Y. L., Newmark, H. L., Conney, A. H., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5362 · Cited by 59
Role of insulin-like growth factor-1R system in colorectal carcinogenesis
Donovan, E. A., & Kummar, S. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.09.003 · Cited by 58
Teicher, B. A., Menon, K., Álvarez, E., et al. (2001) · PubMed · Cited by 58
c-Myc phosphorylation by PKCζ represses prostate tumorigenesis
Kim, J. Y., Valencia, T., Abu‐Baker, S., Linares, J., Lee, S. J., Yajima, T., Chen, J., Eroshkin, A. M., Castilla, E. A., Brill, L. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221799110 · Cited by 57
Yao, S., Bee, A., Brewer, D. S., Dodson, A. R., Beesley, C., Ke, Y., Ambroisine, L., Fisher, G., Møller, H., Dickinson, T., et al. (2010) · Genes & Cancer · doi:10.1177/1947601910376079 · Cited by 56
Protein Kinase C Enzymes in the Hematopoietic and Immune Systems
Altman, A., & Kong, K. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055347 · Cited by 56
PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis
Wang, Y., Justilien, V., Brennan, K., Jamieson, L., Murray, N. R., & Fields, A. P. (2016) · Oncogene · doi:10.1038/onc.2016.224 · Cited by 56
PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL
El‐Gamal, D., Williams, K., LaFollette, T. D., Cannon, M. J., Blachly, J. S., Zhong, Y., Woyach, J. A., Williams, E., Awan, F. T., Jones, J. J., et al. (2014) · Blood · doi:10.1182/blood-2014-05-574830 · Cited by 54
Popp, S., Waltering, S., Boukamp, P., Holtgreve-Grez, H., Jauch, A. S., Proby, C. M., & Leigh, I. M. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00173.x · Cited by 54
Mosior, M. K., & Newton, A. C. (1996) · Biochemistry · doi:10.1021/bi952031q · Cited by 54
Centrosomal PKCβII and Pericentrin Are Critical for Human Prostate Cancer Growth and Angiogenesis
Kim, J., Choi, Y., Vallentin, A., Hunrichs, B. S., Hellerstein, M. K., Peehl, D. M., & Mochly‐Rosen, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6195 · Cited by 54
Kishimoto, A., Takai, Y., & Nishizuka, Y. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40987-2 · Cited by 53
Liu, Y., Su, W., Thompson, E. A., Leitges, M., Murray, N. R., & Fields, A. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407701200 · Cited by 53
Bosco, R., Melloni, E., Celeghini, C., Rimondi, E., Vaccarezza, M., & Zauli, G. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711795049899 · Cited by 53
Protein Kinase C δ Is a Downstream Effector of Oncogenic K-ras in Lung Tumors
Symonds, J. M., Ohm, A. M., Carter, C. J., Heasley, L. E., Boyle, T. A., Franklin, W. A., & Reyland, M. E. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1511 · Cited by 53
Barragán, M., de Frías, M., Iglesias‐Serret, D., Campàs, C., Castaño, E., Santidrián, A. F., Coll-Mulet, L., Cosialls, A. M., Domingo, A., Pons, G., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0106041 · Cited by 52
Protein kinase C eta is associated with progression of renal cell carcinoma (RCC).
Brenner, W., Färber, G., Herget, T., Wiesner, C., Hengstler, J. G., & Thüroff, J. W. (2003) · PubMed · Cited by 50
Teicher, B. A., Menon, K., Álvarez, E., Shih, C., & Faul, M. M. (2002) · Investigational New Drugs · doi:10.1023/a:1016297611825 · Cited by 48
PKCϵ controls protection against TRAIL in erythroid progenitors
Mirandola, P., Gobbi, G., Ponti, C., Sponzilli, I., Cocco, L., & Vitale, M. (2005) · Blood · doi:10.1182/blood-2005-07-2676 · Cited by 48
Phosphorylation is required for PMA- and cell-cycle-induced degradation of protein kinase Cδ
Srivastava, J., Procyk, K. J., Iturrioz, X., & Parker, P. J. (2002) · Biochemical Journal · doi:10.1042/bj20020737 · Cited by 46
Protein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival
Dowling, C. M., Phelan, J. J., Callender, J. A., Cathcart, M. C., Mehigan, B. J., McCormick, P. H., Dalton, T. M., Coffey, J. C., Newton, A. C., O'Sullivan, J. N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8062 · Cited by 45
Prescott, S. L., Irvine, J., Dunstan, J. A., Hii, C. S. T., & Ferrante, A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.045 · Cited by 44
Wu, B., Zhou, H., Hu, L., Mu, Y., & Wu, Y. (2012) · Tumor Biology · doi:10.1007/s13277-012-0614-x · Cited by 43
Gillespie, S., Zhang, X. D., & Hersey, P. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0332 · Cited by 43
Büschenfelde, C. M. Z., Wagner, M. M., Lutzny‐Geier, G., Oelsner, M., Feuerstacke, Y., Decker, T. W., Bogner, C., Peschel, C., & Ringshausen, I. (2009) · Leukemia · doi:10.1038/leu.2009.216 · Cited by 43
Adwan, T. S., Ohm, A. M., Jones, D. N. M., Humphries, M. J., & Reyland, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255950 · Cited by 42
Tachado, S. D., Mayhew, M. W., Wescott, G. G., Foreman, T. L., Goodwin, C. D., McJilton, M. A., & Terrian, D. M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10164 · Cited by 42
Zhao, L., Abdullah, C. S., & Jin, Z. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12621 · Cited by 41
Gwak, J., Jung, S. J., Kang, D., Kim, E. Y., Kim, D., Chung, Y., Shin, J., & Oh, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00683.x · Cited by 41
Doi, S., Goldstein, C., Hug, H., & Weinstein, I. B. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940110405 · Cited by 41
Lam, A. P., Sparano, J. A., Vinciguerra, V. P., Ocean, A. J., Christos, P. J., Höchster, H. S., Camacho, F., Goel, S., Mani, S., & Kaubisch, A. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181a31920 · Cited by 41
A Phase II Trial of ISIS 3521 in Patients with Metastatic Colorectal Cancer
Marshall, J. L., Eisenberg, S. G., Johnson, M. D., Hanfelt, J., Dorr, F. A., El‐Ashry, D., Oberst, M. D., Fuxman, Y., Holmlund, J., & Malik, S. M. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.n.026 · Cited by 40
Shinohara, H., Kayagaki, N., Yagita∥, H., Oyaizu, N., Ohba, M., Kuroki, T., & Ikawa, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5104 · Cited by 40
Clamp, A. R., Blackhall, F. H., Vasey, P. A., Soukop, M., Coleman, R. E., Halbert, G., Robson, L., & Jayson, G. C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601285 · Cited by 39
Novel Protein Kinase C .DELTA. Isoform Insensitive to Caspase-3.
Sakurai, Y., Onishi, Y., Tanimoto, Y., & Kizaki, H. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.973 · Cited by 37
Dainichi, T., Hayden, M. S., Park, S., Oh, H.-J., Seeley, J. J., Grinberg‐Bleyer, Y., Beck, K. M., Miyachi, Y., Kabashima, K., Hashimoto, T., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.051 · Cited by 37
Saravia-Butler, A., Scotti, M. L., Li, S., Smith, K. E., Fields, A. P., & Murray, N. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072061 · Cited by 36
PKCη promotes senescence induced by oxidative stress and chemotherapy
Zurgil, U., Ben-Ari, A., Atias, K., Isakov, N., Apte, R. N., & Livneh, E. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.481 · Cited by 35
Self-citationPhillips, E. S., Lang, V., Bohlen, J., Bethke, F., Puccio, L., Tichy, D., Herold‐Mende, C. C., Hielscher, T., Lichter, P., & Goidts, V. (2016) · International Journal of Cancer · doi:10.1002/ijc.30234 · Cited by 35
Gobbi, G., Mirandola, P., Carubbi, C., Micheloni, C., Malinverno, C., Lunghi, P., Bonati, A., & Vitale, M. (2008) · Blood · doi:10.1182/blood-2008-03-143784 · Cited by 34
A PKC-β inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats
Wei, L., Yin, Z., Yuan, Y., Hwang, A., Lee, A. S., Sun, D., Li, F., Di, C., Zhang, R., Cao, F., et al. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.01.003 · Cited by 34
The C1 Domain of Protein Kinase C as a Lipid Bilayer Surface Sensing Module
Ho, C., Slater, S. J., Stagliano, B. A., & Stubbs, C. D. (2001) · Biochemistry · doi:10.1021/bi002839x · Cited by 30
PLCγ1–PKCγ Signaling‐Mediated Hsp90α Plasma Membrane Translocation Facilitates Tumor Metastasis
Yang, J. M., Song, X., Chen, Y., Lu, X., Fu, Y., & Luo, Y. (2014) · Traffic · doi:10.1111/tra.12179 · Cited by 30
Bryostatin 1: a potential anti-leukemic agent for chronic myelomonocytic leukemia.
Lilly, M., Brown, C., Pettit, G. R., & Kraft, A. S. (1991) · PubMed · Cited by 30
Repression of cancer cell senescence by PKCι
Paget, J., Restall, I. J., Daneshmand, M., Mersereau, J. A., Simard, M. A., Parolin, D. A. E., Lavictoire, S. J., Amin, M. S., Islam, S., & Lorimer, I. A. J. (2011) · Oncogene · doi:10.1038/onc.2011.524 · Cited by 26
Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin.
Lilly, M., Tompkins, C., Brown, C., Pettit, G. R., & Kraft, A. S. (1990) · PubMed · Cited by 26
Ivey, R. A., Sajan, M. P., & Farese, R. V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565671 · Cited by 26
Slosberg, E. D., Yao, Y., Xing, F., Ikui, A. E., Jirousek, M. R., & Weinstein, I. B. (2000) · Molecular Carcinogenesis · Cited by 26
Kim, C. W., Asai, D., Kang, J., Kishimura, A., Mori, T., & Katayama, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3963-4 · Cited by 25
Structural Basis of RasGRP Binding to High-Affinity PKC Ligands
Rong, S.-B., Enyedy, I. J., Qiao, L., Zhao, L., Ma, D., Pearce, L. L., Lorenzo, P. S., Stone, J. C., Blumberg, P. M., Wang, S., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010422z · Cited by 22
Engineered Substrate‐Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics
Qvit, N., Kornfeld, O. S., & Mochly‐Rosen, D. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201605429 · Cited by 21
Armstrong, D. K., Blessing, J. A., Look, K. Y., Schilder, R. J., & Nuñez, E. R. (2003) · Investigational New Drugs · doi:10.1023/a:1025490818450 · Cited by 20
Laudanna, C., Sorio, C., Tecchio, C., Butcher, E. C., Bonora, A., Bassi, C., & Scarpa, A. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000081390.92179.f3 · Cited by 20
PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells
Symonds, J. M., Ohm, A. M., Tan, A. C., & Reyland, M. E. (2016) · Oncotarget · doi:10.18632/oncotarget.7560 · Cited by 17
Mammalian target of rapamycin (mTOR) inhibitors in solid tumours
(2016) · Clinical pharmacist · doi:10.1211/cp.2016.20200813 · Cited by 17
Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers
Gray, J. E., Altiok, S., Alexandrow, M. G., Walsh, F. W., Chen, J., Schell, M. J., Tai, D. F., & Bepler, G. (2012) · Cancer · doi:10.1002/cncr.27836 · Cited by 14
PKCη is an anti-apoptotic kinase that predicts poor prognosis in breast and lung cancer
Zurgil, U., Ben-Ari, A., Rotem‐Dai, N., Karp, G., Krasnitsky, E., Frost, S. A., & Livneh, E. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140182 · Cited by 12
Cited by
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
Oxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 513
Protein kinase C: perfectly balanced
Newton, A. C. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1442408 · Cited by 335
Kolczynska, K., Loza-Valdes, A., Hawro, I., & Sumara, G. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01286-8 · Cited by 199
Novel strategies to reverse chemoresistance in colorectal cancer
Ma, S., Zhang, J., Yan, T., Miao, M., Cao, Y., Cao, Y., Zhang, L., & Li, L. (2023) · Cancer Medicine · doi:10.1002/cam4.5594 · Cited by 108
Metadata
- Authors
- Isakov, N.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 48
- Pages
- 36-52
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2617081687
- Cited by
- 270
- References
- 270
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.